Skip to main content

Compare Stocks

Date Range: 

 ExelixisMedpaceSyneos HealthPRA Health SciencesICON Public
SymbolNASDAQ:EXELNASDAQ:MEDPNASDAQ:SYNHNASDAQ:PRAHNASDAQ:ICLR
Price Information
Current Price$25.21$161.05$85.08$170.36$224.40
52 Week RangeBuyBuyBuyHoldBuy
MarketRank™
Overall Score1.91.21.61.62.0
Analysis Score3.41.31.42.02.4
Community Score2.62.42.82.62.5
Dividend Score0.00.00.00.00.0
Ownership Score1.71.71.71.72.5
Earnings & Valuation Score1.90.61.91.92.5
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldBuy
Consensus Price Target$33.00$131.80$81.64$145.00$236.00
% Upside from Price Target30.90% upside-18.16% downside-4.05% downside-14.89% downside5.17% upside
Trade Information
Market Cap$7.74 billion$5.71 billion$8.57 billion$11.07 billion$12.10 billion
Beta1.211.351.851.240.91
Average Volume2,042,598211,482977,520721,631583,081
Sales & Book Value
Annual Revenue$967.78 million$860.97 million$4.68 billion$3.07 billion$2.81 billion
Price / Sales8.166.731.903.604.29
Cashflow$1.12 per share$4.35 per share$5.90 per share$9.12 per share$9.27 per share
Price / Cash22.4837.0314.4318.6724.21
Book Value$5.55 per share$20.16 per share$29.19 per share$17.23 per share$30.91 per share
Price / Book4.547.992.919.897.26
Profitability
Net Income$321.01 million$100.44 million$131.26 million$243.02 million$373.99 million
EPS$1.02$3.02$2.83$4.80$6.88
Trailing P/E Ratio52.5249.2546.7549.8137.40
Forward P/E Ratio48.4838.1622.7533.4028.51
P/E Growth1.27N/AN/A2.262.85
Net Margins15.88%13.87%4.28%7.09%11.95%
Return on Equity (ROE)8.55%17.67%10.02%22.21%21.42%
Return on Assets (ROA)7.61%10.95%4.06%7.04%11.85%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.81%0.95%N/A
Current Ratio6.99%1.10%1.06%1.13%1.42%
Quick Ratio6.90%1.10%1.06%1.13%1.42%
Ownership Information
Institutional Ownership Percentage81.37%74.44%99.90%96.14%81.70%
Insider Ownership Percentage4.50%26.00%0.44%1.30%44.00%
Miscellaneous
Employees7733,60024,31018,10016,070
Shares Outstanding313.39 million35.97 million104.29 million64.80 million53.62 million
Next Earnings Date8/5/2021 (Estimated)7/26/2021 (Estimated)8/5/2021 (Estimated)8/5/2021 (Estimated)7/28/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
SourceHeadline
ICON Public (NASDAQ:ICLR) PT Raised to $242.00ICON Public (NASDAQ:ICLR) PT Raised to $242.00
americanbankingnews.com - May 10 at 10:30 AM
ICON Public (NASDAQ:ICLR) Sets New 52-Week High After Analyst UpgradeICON Public (NASDAQ:ICLR) Sets New 52-Week High After Analyst Upgrade
americanbankingnews.com - May 6 at 1:08 PM
Jefferies Financial Group Raises ICON Public (NASDAQ:ICLR) Price Target to $267.00Jefferies Financial Group Raises ICON Public (NASDAQ:ICLR) Price Target to $267.00
americanbankingnews.com - May 5 at 1:56 PM
Credit Suisse Group Raises ICON Public (NASDAQ:ICLR) Price Target to $245.00Credit Suisse Group Raises ICON Public (NASDAQ:ICLR) Price Target to $245.00
americanbankingnews.com - May 5 at 1:56 PM
ICON Public (NASDAQ:ICLR) Issues FY 2021 Earnings GuidanceICON Public (NASDAQ:ICLR) Issues FY 2021 Earnings Guidance
americanbankingnews.com - May 5 at 1:02 PM
ICON plc to Present at the BofA Securities 2021 Virtual Healthcare Conference and the UBS Virtual Global Healthcare ConferenceICON plc to Present at the BofA Securities 2021 Virtual Healthcare Conference and the UBS Virtual Global Healthcare Conference
markets.businessinsider.com - May 5 at 7:34 AM
ICON Public (NASDAQ:ICLR) Price Target Raised to $242.00 at MizuhoICON Public (NASDAQ:ICLR) Price Target Raised to $242.00 at Mizuho
americanbankingnews.com - May 3 at 12:52 PM
Short Interest in ICON Public Limited (NASDAQ:ICLR) Expands By 31.4%Short Interest in ICON Public Limited (NASDAQ:ICLR) Expands By 31.4%
americanbankingnews.com - May 2 at 4:48 PM
ICON Public Limited Company 2021 Q1 - Results - Earnings Call PresentationICON Public Limited Company 2021 Q1 - Results - Earnings Call Presentation
seekingalpha.com - April 30 at 4:50 PM
Icon PLC: Q1 Earnings SnapshotIcon PLC: Q1 Earnings Snapshot
sfgate.com - April 30 at 3:05 PM
Baron Funds on ICON Public Ltd Co. (ICLR): “We See Significant Upside in the Stock Price”Baron Funds on ICON Public Ltd Co. (ICLR): “We See Significant Upside in the Stock Price”
finance.yahoo.com - April 30 at 3:05 PM
ICON Public (NASDAQ:ICLR) Posts Quarterly  Earnings Results, Beats Estimates By $0.09 EPSICON Public (NASDAQ:ICLR) Posts Quarterly Earnings Results, Beats Estimates By $0.09 EPS
americanbankingnews.com - April 29 at 2:50 PM
Jefferies Financial Group Boosts ICON Public (NASDAQ:ICLR) Price Target to $267.00Jefferies Financial Group Boosts ICON Public (NASDAQ:ICLR) Price Target to $267.00
americanbankingnews.com - April 29 at 11:42 AM
ICON Public (NASDAQ:ICLR) Given New $245.00 Price Target at Credit Suisse GroupICON Public (NASDAQ:ICLR) Given New $245.00 Price Target at Credit Suisse Group
americanbankingnews.com - April 29 at 10:02 AM
ICON Public (NASDAQ:ICLR) Price Target Increased to $245.00 by Analysts at Credit Suisse GroupICON Public (NASDAQ:ICLR) Price Target Increased to $245.00 by Analysts at Credit Suisse Group
marketbeat.com - April 29 at 9:41 AM
ICON Public (NASDAQ:ICLR) Issues FY21 Earnings GuidanceICON Public (NASDAQ:ICLR) Issues FY21 Earnings Guidance
americanbankingnews.com - April 29 at 12:56 AM
ICON Public (NASDAQ:ICLR) Releases FY 2021 Earnings GuidanceICON Public (NASDAQ:ICLR) Releases FY 2021 Earnings Guidance
americanbankingnews.com - April 28 at 11:36 PM
ICON plc: ICON Reports First Quarter 2021 ResultsICON plc: ICON Reports First Quarter 2021 Results
finanznachrichten.de - April 28 at 8:28 PM
ICON Reports First Quarter 2021 ResultsICON Reports First Quarter 2021 Results
finance.yahoo.com - April 28 at 8:28 PM
Icon PLC (ICLR) Q1 Earnings and Revenues Top EstimatesIcon PLC (ICLR) Q1 Earnings and Revenues Top Estimates
finance.yahoo.com - April 28 at 8:28 PM
Investors Who Bought ICON (NASDAQ:ICLR) Shares Five Years Ago Are Now Up 232%Investors Who Bought ICON (NASDAQ:ICLR) Shares Five Years Ago Are Now Up 232%
finance.yahoo.com - April 28 at 10:26 AM
Details emerge in attempted carjacking at San Angelo ICON Cinema, Mississippi man arrestedDetails emerge in attempted carjacking at San Angelo ICON Cinema, Mississippi man arrested
gosanangelo.com - April 22 at 8:37 PM
ICON wins multiple categories in 2021 CRO Leadership Awards for the fourth year in a rowICON wins multiple categories in 2021 CRO Leadership Awards for the fourth year in a row
finance.yahoo.com - April 20 at 10:00 AM
Short Interest in ICON Public Limited (NASDAQ:ICLR) Rises By 27.8%Short Interest in ICON Public Limited (NASDAQ:ICLR) Rises By 27.8%
americanbankingnews.com - April 19 at 11:20 AM
Icon PLC (ICLR) Soars 4.5%: Is Further Upside Left in the Stock?Icon PLC (ICLR) Soars 4.5%: Is Further Upside Left in the Stock?
finance.yahoo.com - April 16 at 9:21 AM
Is ICLR Stock A Buy or Sell?Is ICLR Stock A Buy or Sell?
finance.yahoo.com - April 14 at 1:08 PM
DateCompanyBrokerageAction
4/26/2021ExelixisMorgan StanleyLower Price Target
3/30/2021ExelixisCredit Suisse GroupInitiated Coverage
3/17/2021ExelixisWolfe ResearchInitiated Coverage
2/16/2021ExelixisPiper SandlerBoost Price Target
1/15/2021ExelixisWilliam BlairReiterated Rating
10/26/2020ExelixisStifel NicolausBoost Price Target
9/21/2020ExelixisOppenheimerBoost Price Target
7/8/2020ExelixisSunTrust BanksReiterated Rating
5/6/2020ExelixisBMO Capital MarketsBoost Price Target
5/6/2020ExelixisNeedham & Company LLCReiterated Rating
4/21/2020ExelixisGuggenheimBoost Price Target
4/21/2020ExelixisBarclaysReiterated Rating
2/17/2021MedpaceTruistBoost Price Target
6/8/2020MedpaceRobert W. BairdUpgrade
3/23/2020MedpaceJefferies Financial GroupLower Price Target
2/25/2020MedpaceCSFBBoost Price Target
5/6/2021Syneos HealthMizuhoBoost Price Target
3/15/2021Syneos HealthKeyCorpBoost Price Target
2/19/2021Syneos HealthCitigroupBoost Price Target
12/9/2020Syneos HealthCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target
12/9/2020Syneos HealthJPMorgan Chase & Co.Boost Price Target
12/9/2020Syneos HealthSmith Barney CitigroupBoost Price Target
10/1/2020Syneos HealthThe Goldman Sachs GroupUpgrade
8/12/2020Syneos HealthTruist FinancialBoost Price Target
4/30/2020Syneos HealthCfraBoost Price Target
4/28/2020Syneos HealthUBS GroupLower Price Target
5/10/2021PRA Health SciencesTruist SecuritiesDowngrade
8/10/2020PRA Health SciencesBank of AmericaDowngrade
4/1/2021ICON PublicWells Fargo & CompanyUpgrade
3/3/2021ICON PublicDeutsche Bank AktiengesellschaftBoost Price Target
(Data available from 5/12/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.